JPY 136.0
(-2.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -284.4 Million | -558.21 Million | -439.73 Million | -626.03 Million | 46.08 Million | -285.43 Million |
Net Income | -609.91 Million | -857.39 Million | -356.29 Million | -265.26 Million | 99.89 Million | -229.02 Million |
Depreciation & Amortization | 41.1 Million | 15.17 Million | 13.87 Million | 14.67 Million | 12.71 Million | 13.24 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 211.34 Million | 210.93 Million | -111.67 Million | -366.86 Million | -66.43 Million | -77.71 Million |
Other non-cash items | 73.05 Million | 73.06 Million | 14.36 Million | -8.59 Million | -91 Thousand | 8.06 Million |
Investing Cash Flow | 42.63 Million | -8.74 Million | -61.18 Million | -36.84 Million | -11.12 Million | -6.13 Million |
Investments in PPE | -9 Million | -13.08 Million | -4.94 Million | -33.56 Million | -5.31 Million | -3.66 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -59 Thousand | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 51.63 Million | 4.4 Million | -56.23 Million | -3.27 Million | -5.81 Million | -2.47 Million |
Financing Cash Flow | 219.74 Million | 832.33 Million | 671.48 Million | 731.43 Million | 76.67 Million | 9.53 Million |
Debt repayment | -85.76 Million | -69.32 Million | -44.66 Million | -6.66 Million | -23.32 Million | -9.17 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -50 Thousand | -197 Thousand | - | - | - |
Common Stock Issuance | 700.29 Million | 28.89 Million | 1.03 Billion | 69.6 Million | - | 8.7 Million |
Other Financing Activities | -394.78 Million | 872.8 Million | -1000.00 | 668.5 Million | 100 Million | 10 Million |
Accounts receivables | 61.21 Million | 17.23 Million | -33.89 Million | -82.03 Million | 44.99 Million | -59.52 Million |
Accounts payables | - | - | - | - | -3.27 Million | -50.83 Million |
Inventory | - | - | - | - | -2.26 Million | - |
Other working capital | 150.13 Million | 193.7 Million | -77.78 Million | -284.82 Million | -105.89 Million | 34.9 Million |
Cash at beginning of period | 894.62 Million | 629.15 Million | 459.2 Million | 391.38 Million | 279.68 Million | 561.71 Million |
Cash at end of period | 872.6 Million | 894.62 Million | 629.15 Million | 459.2 Million | 391.38 Million | 279.68 Million |
Capital Expenditure | -9 Million | -13.08 Million | -4.94 Million | -33.56 Million | -5.31 Million | -3.66 Million |
Effect of forex changes on cash | -1000.00 | 98 Thousand | -609 Thousand | -724 Thousand | 60 Thousand | -1000.00 |
Net cash flow / Change in cash | -22.01 Million | 265.46 Million | 169.95 Million | 67.82 Million | 111.7 Million | -282.03 Million |
Free Cash Flow | -293.4 Million | -571.3 Million | -444.68 Million | -659.6 Million | 40.77 Million | -289.09 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -42 Million | -8 Million | -56 Million | -609.91 Million | -172 Million | -182 Million |
Depreciation & Amortization | - | - | 41.1 Million | 41.1 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 211.34 Million | - | - |
Other non-cash items | 42 Million | 8 Million | 56 Million | 73.05 Million | 172 Million | 182 Million |
Investing Cash Flow | - | - | - | 42.63 Million | - | - |
Investments in PPE | - | - | - | -9 Million | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | 51.63 Million | - | - |
Financing Cash Flow | - | - | - | 219.74 Million | - | - |
Debt repayment | - | - | - | -85.76 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 700.29 Million | - | - |
Other Financing Activities | - | - | - | -394.78 Million | - | - |
Accounts receivables | - | - | - | 61.21 Million | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | 150.13 Million | - | - |
Cash at beginning of period | - | 872.6 Million | 850.75 Million | 894.62 Million | 974.39 Million | 1.11 Billion |
Cash at end of period | - | 817.16 Million | 872.6 Million | 872.6 Million | 850.75 Million | 974.39 Million |
Capital Expenditure | - | - | - | -9 Million | - | - |
Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
Net cash flow / Change in cash | - | -55.44 Million | 21.84 Million | -22.01 Million | -123.64 Million | -138.45 Million |
Free Cash Flow | - | - | 82.2 Million | -293.4 Million | - | - |
CCG
SICAGEN
2351
2038
603636
GDV